Discover
LENZ
LENZ Therapeutics, Inc.
5.79
2 x 4.27
2 x 7.24
bid
ask
+
0.11
1.94%
2 @ 05:57 AM
5.80 +0.01 (0.17%)
| Ytd | -63.81% | |
| 1y | -81.30% |
5.57
day range
5.98
5.23
52 week range
50.40
| Open | 5.60 | Prev Close | 5.68 | Low | 5.57 | High | 5.98 | Mkt Cap | 181.54M |
| Vol | 523.99K | Avg Vol | 779.99K | EPS | -3.64 | P/E | N/A | Forward P/E | -13.35 |
| Beta | N/A | Short Ratio | 13.18 | Inst. Own | 99.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 7.61 | 200-d Avg | 18.66 | 1yr Est | 54.25 |
| Income Statement | |||
| Total Revenue | 1.90M | ||
| Revenues (USD) | 1.90M | ||
| Cost of Revenue | 1.08M | ||
| Gross Profit | 825.00K | ||
| Operating Expenses | 44.96M | ||
| Selling, General and Administrative Expense | 44.96M | ||
| Operating Income | -44.13M | ||
| Net Income | -41.49M | ||
| Net Income Common Stock | -41.49M | ||
| Net Income Common Stock (USD) | -41.49M | ||
| Consolidated Income | -41.49M | ||
| Earnings per Basic Share | -1.32 | ||
| Earnings per Basic Share (USD) | -1.32 | ||
| Earnings per Diluted Share | -1.32 | ||
| Earning Before Interest & Taxes (EBIT) | -41.49M | ||
| Earning Before Interest & Taxes (USD) | -41.49M | ||
| Weighted Average Shares | 31.35M | ||
| Weighted Average Shares Diluted | 31.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.77M | ||
| Cash and Equivalents (USD) | 24.77M | ||
| Investments | 233.61M | ||
| Investments Current | 233.61M | ||
| Trade and Non-Trade Receivables | 343.00K | ||
| Current Assets | 268.37M | ||
| Property, Plant & Equipment Net | 1.72M | ||
| Total Assets | 272.54M | ||
| Total Debt | 237.00K | ||
| Current Liabilities | 25.81M | ||
| Debt Non-Current | 237.00K | ||
| Total Liabilities | 26.04M | ||
| Accumulated Retained Earnings (Deficit) | -268.63M | ||
| Accumulated Other Comprehensive Income | -450.00K | ||
| Shareholders Equity | 246.49M | ||
| Shareholders Equity (USD) | 246.49M | ||
| Assets Non-Current | 4.17M | ||
| Total Debt (USD) | 237.00K | ||
| Inventory | 3.50M | ||
| Liabilities Non-Current | 237.00K | ||
| Trade and Non-Trade Payables | 10.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 111.00K | ||
| Net Cash Flow from Financing | 14.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -407.00K | ||
| Capital Expenditure | -18.00K | ||
| Issuance (Purchase) of Equity Shares | 14.00K | ||
| Net Cash Flow from Investing | 33.16M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 33.18M | ||
| Net Cash Flow from Operations | -33.58M | ||
| Share Based Compensation | 4.32M | ||